Does LISOCABTAGENE MARALEUCEL Cause Atrial fibrillation? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Atrial fibrillation have been filed in association with LISOCABTAGENE MARALEUCEL (BREYANZI). This represents 1.0% of all adverse event reports for LISOCABTAGENE MARALEUCEL.
7
Reports of Atrial fibrillation with LISOCABTAGENE MARALEUCEL
1.0%
of all LISOCABTAGENE MARALEUCEL reports
2
Deaths
4
Hospitalizations
How Dangerous Is Atrial fibrillation From LISOCABTAGENE MARALEUCEL?
Of the 7 reports, 2 (28.6%) resulted in death, 4 (57.1%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Atrial fibrillation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LISOCABTAGENE MARALEUCEL. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does LISOCABTAGENE MARALEUCEL Cause?
Cytokine release syndrome (315)
Immune effector cell-associated neurotoxicity syndrome (129)
Neurotoxicity (101)
Pyrexia (47)
Fatigue (38)
Hypotension (38)
Febrile neutropenia (28)
Confusional state (27)
Death (25)
Lymphocyte adoptive therapy (25)
What Other Drugs Cause Atrial fibrillation?
APIXABAN (5,690)
IBRUTINIB (3,671)
LENALIDOMIDE (2,704)
RITUXIMAB (2,100)
SACUBITRIL\VALSARTAN (2,062)
RIVAROXABAN (2,027)
ADALIMUMAB (1,709)
METOPROLOL (1,462)
DEXAMETHASONE (1,461)
METHOTREXATE (1,411)
Which LISOCABTAGENE MARALEUCEL Alternatives Have Lower Atrial fibrillation Risk?
LISOCABTAGENE MARALEUCEL vs LITHIUM
LISOCABTAGENE MARALEUCEL vs LIXISENATIDE
LISOCABTAGENE MARALEUCEL vs LOBAPLATIN
LISOCABTAGENE MARALEUCEL vs LOFEXIDINE
LISOCABTAGENE MARALEUCEL vs LOMITAPIDE